Phase III Study to Evaluate the Efficacy and Safety of AGSAVI in Patients With Essential Hypertension
Clinical trial NCT04686643 · UNKNOWN
Trial details
- NCT number
- NCT04686643
- Sponsor
- Ahn-Gook Pharmaceuticals Co.,Ltd
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-01
- Primary completion
- 2022-02-01
- Enrollment
- 306
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.